Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Hepatocellular Carcinoma”

1,154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,154 results

Early research (Phase 1)Study completedNCT01656265
What this trial is testing

Study of ARQ 197 in Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
Kyowa Kirin Co., Ltd. 24
Not applicableLooking for participantsNCT06887348
What this trial is testing

Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Who this might be right for
MelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more
Replimune Inc. 50
Early research (Phase 1)Looking for participantsNCT06307925
What this trial is testing

A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
HC Biopharma Inc. 122
Early research (Phase 1)Looking for participantsNCT06326502
What this trial is testing

A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAdvanced Hepatocellular CarcinomaLiver Cancer
Etnova Therapeutics Corp. 50
Testing effectiveness (Phase 2)Looking for participantsNCT07227012
What this trial is testing

Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Who this might be right for
Carcinoma, HepatocellularHepatocellular CancerHepatocellular Carcinoma+4 more
Pfizer 138
Testing effectiveness (Phase 2)Study completedNCT00987935
What this trial is testing

A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients

Who this might be right for
Carcinoma, Hepatocellular
Boehringer Ingelheim 134
Testing effectiveness (Phase 2)UnknownNCT05603039
What this trial is testing

A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Liver Cancer
Qilu Pharmaceutical Co., Ltd. 80
Not applicableLooking for participantsNCT06061276
What this trial is testing

BTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

Who this might be right for
Liver DiseasesHepatocellular CarcinomaImmunotherapy+2 more
Sun Yat-sen University 40
Testing effectiveness (Phase 2)UnknownNCT05622136
What this trial is testing

Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Liver CancerHepatocellular Carcinoma
Instituto do Cancer do Estado de São Paulo 28
Testing effectiveness (Phase 2)UnknownNCT05171309
What this trial is testing

Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 35
Testing effectiveness (Phase 2)Ended earlyNCT03970616
What this trial is testing

Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AVEO Pharmaceuticals, Inc. 27
Early research (Phase 1)Not Yet RecruitingNCT06822985
What this trial is testing

QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Wan-Guang Zhang 21
Testing effectiveness (Phase 2)Study completedNCT00940225
What this trial is testing

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Who this might be right for
Solid TumorsCancer
Exelixis 730
Early research (Phase 1)Active Not RecruitingNCT02817633
What this trial is testing

TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Who this might be right for
Neoplasms
Tesaro, Inc. 463
Testing effectiveness (Phase 2)Ended earlyNCT00862082
What this trial is testing

Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Proacta, Incorporated 14
Early research (Phase 1)Study completedNCT01337050
What this trial is testing

Asian Phase I Study Of PF-03446962

Who this might be right for
Neoplasms
Pfizer 36
Testing effectiveness (Phase 2)Study completedNCT04798781
What this trial is testing

Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma

Who this might be right for
Gastric CancerHepatocellular Carcinoma
Andrew Hendifar, MD 16
Testing effectiveness (Phase 2)UnknownNCT04014101
What this trial is testing

SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 40
Testing effectiveness (Phase 2)Study completedNCT04444167
What this trial is testing

Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Akeso 59
Testing effectiveness (Phase 2)Study completedNCT05517239
What this trial is testing

Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment

Who this might be right for
Hepatocellular Carcinoma, Unresectable, Advanced
Yonsei University 32
Load More Results